ACB vs. THCX, CRON, TLRY, GUD, WEED, FIRE, EPI, CPH, ICC, and RIV
Should you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Hydropothecary (THCX), Cronos Group (CRON), Tilray Brands (TLRY), Knight Therapeutics (GUD), Canopy Growth (WEED), Supreme Cannabis (FIRE), ESSA Pharma (EPI), Cipher Pharmaceuticals (CPH), ICC Labs (ICC), and RIV Capital (RIV). These companies are all part of the "drug manufacturers - specialty & generic" industry.
Aurora Cannabis vs.
Hydropothecary (CVE:THCX) and Aurora Cannabis (TSE:ACB) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, community ranking, valuation, earnings, dividends and media sentiment.
In the previous week, Aurora Cannabis had 1 more articles in the media than Hydropothecary. MarketBeat recorded 1 mentions for Aurora Cannabis and 0 mentions for Hydropothecary. Hydropothecary's average media sentiment score of 0.00 equaled Aurora Cannabis'average media sentiment score.
Hydropothecary has higher earnings, but lower revenue than Aurora Cannabis.
13.4% of Aurora Cannabis shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Aurora Cannabis received 390 more outperform votes than Hydropothecary when rated by MarketBeat users. However, 72.31% of users gave Hydropothecary an outperform vote while only 63.14% of users gave Aurora Cannabis an outperform vote.
Hydropothecary has a net margin of 0.00% compared to Aurora Cannabis' net margin of -22.55%. Hydropothecary's return on equity of 0.00% beat Aurora Cannabis' return on equity.
Aurora Cannabis has a consensus price target of C$8.75, indicating a potential upside of 32.58%. Given Aurora Cannabis' stronger consensus rating and higher possible upside, analysts clearly believe Aurora Cannabis is more favorable than Hydropothecary.
Summary
Aurora Cannabis beats Hydropothecary on 7 of the 11 factors compared between the two stocks.
Get Aurora Cannabis News Delivered to You Automatically
Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aurora Cannabis Competitors List
Related Companies and Tools
This page (TSE:ACB) was last updated on 3/28/2025 by MarketBeat.com Staff
Buy ACB Stock Free ACB Stock Alerts